首站-论文投稿智能助手
典型文献
Antiatherosclerotic effect of dehydrocorydaline on ApoE-/-mice:inhibition of macrophage inflammation
文献摘要:
Despite improvements in cardiovascular disease(CVD)outcomes by cholesterol-lowering statin therapy,the high rate of CVD is still a great concern worldwide.Dehydrocorydaline(DHC)is an alkaloidal compound isolated from the traditional Chinese herb Corydalis yanhusuo.Emerging evidence shows that DHC has anti-inflammatory and antithrombotic benefits,but whether DHC exerts any antiatherosclerotic effects remains unclear.Our study revealed that intraperitoneal(i.p.)injection of DHC in apolipoprotein E-deficient(ApoE-/-)mice not only inhibited atherosclerosis development but also improved aortic compliance and increased plaque stability.In addition,DHC attenuated systemic and vascular inflammation in ApoE-/-mice.As macrophage inflammation plays an essential role in the pathogenesis of atherosclerosis,we next examined the direct effects of DHC on bone marrow-derived macrophages(BMDMs)in vitro.Our RNA-seq data revealed that DHC dramatically decreased the levels of proinflammatory gene clusters.We verified that DHC significantly downregulated proinflammatory interleukin(IL)-1β and IL-18 mRNA levels in a time-and concentration-dependent manner.Furthermore,DHC decreased lipopolysaccharide(LPS)-induced inflammation in BMDMs,as evidenced by the reduced protein levels of CD80,iNOS,NLRP3,IL-1β,and IL-18.Importantly,DHC attenuated LPS-induced activation of p65 and the extracellular signal-regulated kinase 1/2(ERK1/2)pathway.Thus,we conclude that DHC ameliorates atherosclerosis in ApoE-/-mice by inhibiting inflammation,likely by targeting macrophage p65-and ERK1/2-mediated pathways.
文献关键词:
作者姓名:
Bin Wen;Yuan-ye Dang;Su-hua Wu;Yi-min Huang;Kong-yang Ma;Yi-ming Xu;Xi-Long Zheng;Xiao-yan Dai
作者机构:
Guangdong Provincial Key Laboratory of Molecular Target&Clinical Pharmacology,School of Pharmaceutical Sciences,Guangzhou Medical University,Guangzhou 511436,China;China Centre for Infection and Immunity Studies(CIIS),School of Medicine,Sun Yat-sen University,Shenzhen 518107,China;School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Department of Biochemistry&Molecular Biology,Cumming School of Medicine,University of Calgary,Calgary,AB,Canada
引用格式:
[1]Bin Wen;Yuan-ye Dang;Su-hua Wu;Yi-min Huang;Kong-yang Ma;Yi-ming Xu;Xi-Long Zheng;Xiao-yan Dai-.Antiatherosclerotic effect of dehydrocorydaline on ApoE-/-mice:inhibition of macrophage inflammation)[J].中国药理学报(英文版),2022(06):1408-1418
A类:
Antiatherosclerotic,dehydrocorydaline,Dehydrocorydaline,alkaloidal,antiatherosclerotic
B类:
ApoE,mice,inhibition,inflammation,Despite,improvements,cardiovascular,disease,CVD,outcomes,by,cholesterol,lowering,statin,therapy,high,still,great,concern,worldwide,DHC,compound,isolated,from,traditional,Chinese,herb,Corydalis,yanhusuo,Emerging,shows,that,has,antithrombotic,benefits,but,whether,exerts,any,effects,remains,unclear,Our,study,revealed,intraperitoneal,injection,apolipoprotein,deficient,not,only,inhibited,atherosclerosis,development,also,improved,aortic,compliance,increased,plaque,stability,In,addition,attenuated,systemic,plays,essential,role,pathogenesis,next,examined,direct,bone,marrow,derived,macrophages,BMDMs,vitro,seq,data,dramatically,decreased,levels,proinflammatory,clusters,We,verified,significantly,downregulated,interleukin,concentration,dependent,manner,Furthermore,lipopolysaccharide,LPS,induced,evidenced,reduced,CD80,iNOS,NLRP3,Importantly,activation,p65,extracellular,signal,kinase,ERK1,Thus,conclude,ameliorates,inhibiting,likely,targeting,mediated,pathways
AB值:
0.54983
相似文献
FGF2 is overexpressed in asthma and promotes airway inflammation through the FGFR/MAPK/NF-κB pathway in airway epithelial cells
Yuan-Yang Tan;Hui-Qin Zhou;Yu-Jing Lin;Liu-Tong Yi;Zhuang-Gui Chen;Qing-Dong Cao;Yan-Rong Guo;Zhao-Ni Wang;Shou-Deng Chen;Yang Li;De-Yun Wang;Yong-Kang Qiao;Yan Yan-Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Pathology,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Pediatrics,the Third Affiliated Hospital,Sun Yat-Sen University,Guangzhou 510630,China;Department of Cardiothoracic Surgery,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China;Department of Otolaryngology,Yong Loo Lin School of Medicine,National University Health System,National University of Singapore,Singapore 119228,Singapore;BGI-Shenzhen,Shenzhen 518083,Guangdong,China;Central Laboratory,the Fifth Affiliated Hospital,Sun Yat-Sen University,Zhuhai 519000,Guangdong,China
Therapeutic effects of the extract of Sancao Formula,a Chinese herbal compound,on imiquimod-induced psoriasis via cysteine-rich protein 61
Wan-jun Guo;Yi Wang;Yu Deng;Lin-yan Cheng;Xin Liu;Ruo-fan Xi;Sheng-jie Zhu;Xin-yi Feng;Liang Hua;Kan Ze;Jian-yong Zhu;Dong-jie Guo;Fu-lun Li-Department of Dermatology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China;School of Medicine,Chengdu University,Chengdu 610106,Sichuan Province,China;Institute of Cancer Biology and Drug Discovery,Chengdu University,Chengdu 610106,Sichuan Province,China;Clinical Laboratory Medicine Center,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。